¡Hola! Iniciá sesión
Inicio > Productos

Havard’s Nursing Guide to Drugs

$93.582,00
10% de descuento pagando con Transferencia
Ver más detalles

FORMATO

Edicion

PAPEL

Edicion

EBOOK
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Essential reference for students and clinicians


Havard’s Nursing Guide to Drugs is an indispensable guide for nurses and nursing students that can be used both as a quick reference for medicine information and to acquire a deeper understanding for safe and effective drug administration by nurses.


The guide is accessible and user friendly. It provides all the information you need for safe administration of medication, with drugs classified by both therapeutic class and body system for easy navigation.


The twelfth edition has been comprehensively reviewed and updated to ensure that usage, dose, side-effects, contraindications and precautions are consistent with current Australian pharmaceutical guidelines.

  • Easy-to-use format – search for drugs by therapeutic class or body system
  • All the important information nurses need – poisons information, formulae for calculations of drug doses and drip rates
  • Nursing considerations such as patient safety, administration advice and cautions
  • Drug monographs include active ingredient and trade names, available forms, action, use, dosage, adverse effects and interactions
  • Patient education and advice notes to improve patient care and outcomes
  • A separate durable pocket card suitable for attaching to a lanyard with formulae, useful units and concentrations, and common abbreviations
  • Available in print and eBook

New to this edition

  • Each drug reviewed to ensure its relevance for nurses in Australia
  • Chapter introductions updated citing the latest evidence, in a language that promotes nurse and nursing student understanding
  • Updated icons offering a quick visual guide, helping readers locate key drug information including pregnancy and breastfeeding safety, crushability, dosage adjustments, and considerations for older adults and in sports
  • Therapeutic Goods Administration drug scheduling incorporated specifically for Schedule 8 medications

1. INTRODUCTION - p. ix 2. GUIDE TO TEXT - p. xxv 3. GENERAL PATIENT EDUCATION - p. xxvii 4. REVIEWERS - p. xxxiii 5. Chapter 1: ACNE TREATMENT - p. xxxiv 6. Chapter 2: ANALGESICS AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) - p. 9 7. Chapter 3: ANORECTICS AND WEIGHT-LOSS AGENTS - p. 34 8. Chapter 4: ANTHELMINTICS - p. 41 9. Chapter 5: ANTIALZHEIMER’S AGENTS - p. 49 10. Chapter 6: ANTIANGINAL AGENTS - p. 57 11. Chapter 7: ANTIANXIETY AGENTS - p. 69 12. Chapter 8: ANTIARRHYTHMIC AGENTS - p. 78 13. Chapter 9: ANTIASTHMA AGENTS, BRONCHODILATORS AND RESPIRATORY AGENTS - p. 96 14. Chapter 10: ANTIBACTERIAL AGENTS - p. 146 15. Chapter 11: ANTICOAGULANTS AND ANTITHROMBOTIC AGENTS - p. 235 16. Chapter 12: ANTIDEPRESSANTS - p. 263 17. Chapter 13: ANTIDIABETIC AGENTS - p. 295 18. Chapter 14: ANTIDIARRHOEAL AGENTS - p. 329 19. Chapter 15: ANTIDOTES, ANTAGONISTS AND CHELATING AGENTS - p. 333 20. Chapter 16: ANTIEMETIC AGENTS - p. 367 21. Chapter 17: ANTIEPILEPTICS - p. 383 22. Chapter 18: ANTIFUNGAL AGENTS - p. 427 23. Chapter 19: ANTIGLAUCOMA AGENTS - p. 459 24. Chapter 20: ANTIGOUT AND URICOLYTIC AGENTS - p. 472 25. Chapter 21: ANTIHISTAMINES - p. 483 26. Chapter 22: ANTIHYPERTENSIVE AGENTS - p. 498 27. Chapter 23: ANTIMALARIAL AGENTS - p. 554 28. Chapter 24: ANTIMIGRAINE AGENTS - p. 568 29. Chapter 25: ANTIMYCOBACTERIAL AGENTS - p. 583 30. Chapter 26: ANTINEOPLASTIC AGENTS - p. 594 31. Chapter 27: ANTINEOPLASTIC THERAPY SUPPORT AGENTS - p. 779 32. Chapter 28: ANTI-PARKINSON’S AGENTS - p. 789 33. Chapter 29: ANTIPLATELET AGENTS - p. 816 34. Chapter 30: ANTIPROTOZOAL AGENTS - p. 824 35. Chapter 31: ANTIPSYCHOTIC AND MOOD-STABILISING AGENTS - p. 832 36. Chapter 32: ANTIULCER AGENTS - p. 870 37. Chapter 33: ANTIVENOMS - p. 888 38. Chapter 34: ANTIVIRAL AGENTS - p. 896 39. Chapter 35: BLADDER FUNCTION DISORDER AGENTS - p. 941 40. Chapter 36: BONE AND CALCIUM REGULATING AGENTS - p. 956 41. Chapter 37: CARDIAC GLYCOSIDES - p. 978 42. Chapter 38: CHOLINERGIC AND ANTICHOLINERGIC AGENTS - p. 980 43. Chapter 39: CORTICOSTEROIDS - p. 990 44. Chapter 40: COUGH SUPPRESSANTS AND EXPECTORANTS - p. 1018 45. Chapter 41: DERMATOLOGICAL AGENTS - p. 1023 46. Chapter 42: DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) - p. 1037 47. Chapter 43: DIURETICS - p. 1078 48. Chapter 44: DRUG DEPENDENCE - p. 1101 49. Chapter 45: ERECTILE DYSFUNCTION AGENTS - p. 1115 50. Chapter 46: EYE, EAR, NOSE AND THROAT AGENTS - p. 1127 51. Chapter 47: FIBRINOLYTIC AGENTS - p. 1150 52. Chapter 48: GASTROINTESTINAL AGENTS (MISCELLANEOUS) - p. 1155 53. Chapter 49: GENERAL ANAESTHETICS - p. 1171 54. Chapter 50: HAEMOPOIETIC AGENTS - p. 1183 55. Chapter 51: HAEMOSTATICS - p. 1193 56. Chapter 52: HYPOTHALAMIC AND PITUITARY HORMONES - p. 1215 57. Chapter 53: IMMUNOMODIFIERS - p. 1236 58. Chapter 54: LAXATIVES - p. 1284 59. Chapter 55: LIPID REGULATING AGENTS - p. 1298 60. Chapter 56: LOCAL ANAESTHETICS - p. 1320 61. Chapter 57: METABOLIC DISORDERS AGENTS - p. 1335 62. Chapter 58: MOVEMENT DISORDER AGENTS - p. 1367 63. Chapter 59: MUSCLE RELAXANTS - p. 1401 64. Chapter 60: NEUROMUSCULAR BLOCKING AGENTS - p. 1419 65. Chapter 61: OPIOID ANALGESICS - p. 1428 66. Chapter 62: PREGNANCY, CHILDBIRTH AND BREASTFEEDING - p. 1455 67. Chapter 63: PULMONARY HYPERTENSION AGENTS - p. 1489 68. Chapter 64: SEDATIVESAND HYPNOTICS - p. 1501 69. Chapter 65: SEX HORMONES - p. 1518 70. Chapter 66: STIMULANTS - p. 1550 71. Chapter 67: SYMPATHOMIMETIC AGENTS - p. 1564 72. Chapter 68: THYROID AND ANTITHYROID AGENTS - p. 1578 73. Chapter 69: VACCINES AND IMMUNOGLOBULINS - p. 1590 74. Chapter 70: VASODILATORS - p. 1631 75. Chapter 71: VITAMINS, MINERALS AND ELECTROLYTES - p. 1635 76. Chapter 72: MISCELLANEOUS AGENTS - p. 1670 77. APPENDIX 1: POISONING AND ITS TREATMENT - p. 1681 78. APPENDIX 2: POISONS INFORMATION CENTRES - p. 1686 79. APPENDIX 3: CHANGES TO DRUG NAMES - p. 1687 80. BIBLIOGRAPHY - p. 1689 81. GLOSSARY - p. 1708 82. INDEX - p. 1715 83. Inside Back Cover - p. 1715

Descripcion
Descripción

Essential reference for students and clinicians


Havard’s Nursing Guide to Drugs is an indispensable guide for nurses and nursing students that can be used both as a quick reference for medicine information and to acquire a deeper understanding for safe and effective drug administration by nurses.


The guide is accessible and user friendly. It provides all the information you need for safe administration of medication, with drugs classified by both therapeutic class and body system for easy navigation.


The twelfth edition has been comprehensively reviewed and updated to ensure that usage, dose, side-effects, contraindications and precautions are consistent with current Australian pharmaceutical guidelines.

  • Easy-to-use format – search for drugs by therapeutic class or body system
  • All the important information nurses need – poisons information, formulae for calculations of drug doses and drip rates
  • Nursing considerations such as patient safety, administration advice and cautions
  • Drug monographs include active ingredient and trade names, available forms, action, use, dosage, adverse effects and interactions
  • Patient education and advice notes to improve patient care and outcomes
  • A separate durable pocket card suitable for attaching to a lanyard with formulae, useful units and concentrations, and common abbreviations
  • Available in print and eBook

New to this edition

  • Each drug reviewed to ensure its relevance for nurses in Australia
  • Chapter introductions updated citing the latest evidence, in a language that promotes nurse and nursing student understanding
  • Updated icons offering a quick visual guide, helping readers locate key drug information including pregnancy and breastfeeding safety, crushability, dosage adjustments, and considerations for older adults and in sports
  • Therapeutic Goods Administration drug scheduling incorporated specifically for Schedule 8 medications

1. INTRODUCTION - p. ix 2. GUIDE TO TEXT - p. xxv 3. GENERAL PATIENT EDUCATION - p. xxvii 4. REVIEWERS - p. xxxiii 5. Chapter 1: ACNE TREATMENT - p. xxxiv 6. Chapter 2: ANALGESICS AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) - p. 9 7. Chapter 3: ANORECTICS AND WEIGHT-LOSS AGENTS - p. 34 8. Chapter 4: ANTHELMINTICS - p. 41 9. Chapter 5: ANTIALZHEIMER’S AGENTS - p. 49 10. Chapter 6: ANTIANGINAL AGENTS - p. 57 11. Chapter 7: ANTIANXIETY AGENTS - p. 69 12. Chapter 8: ANTIARRHYTHMIC AGENTS - p. 78 13. Chapter 9: ANTIASTHMA AGENTS, BRONCHODILATORS AND RESPIRATORY AGENTS - p. 96 14. Chapter 10: ANTIBACTERIAL AGENTS - p. 146 15. Chapter 11: ANTICOAGULANTS AND ANTITHROMBOTIC AGENTS - p. 235 16. Chapter 12: ANTIDEPRESSANTS - p. 263 17. Chapter 13: ANTIDIABETIC AGENTS - p. 295 18. Chapter 14: ANTIDIARRHOEAL AGENTS - p. 329 19. Chapter 15: ANTIDOTES, ANTAGONISTS AND CHELATING AGENTS - p. 333 20. Chapter 16: ANTIEMETIC AGENTS - p. 367 21. Chapter 17: ANTIEPILEPTICS - p. 383 22. Chapter 18: ANTIFUNGAL AGENTS - p. 427 23. Chapter 19: ANTIGLAUCOMA AGENTS - p. 459 24. Chapter 20: ANTIGOUT AND URICOLYTIC AGENTS - p. 472 25. Chapter 21: ANTIHISTAMINES - p. 483 26. Chapter 22: ANTIHYPERTENSIVE AGENTS - p. 498 27. Chapter 23: ANTIMALARIAL AGENTS - p. 554 28. Chapter 24: ANTIMIGRAINE AGENTS - p. 568 29. Chapter 25: ANTIMYCOBACTERIAL AGENTS - p. 583 30. Chapter 26: ANTINEOPLASTIC AGENTS - p. 594 31. Chapter 27: ANTINEOPLASTIC THERAPY SUPPORT AGENTS - p. 779 32. Chapter 28: ANTI-PARKINSON’S AGENTS - p. 789 33. Chapter 29: ANTIPLATELET AGENTS - p. 816 34. Chapter 30: ANTIPROTOZOAL AGENTS - p. 824 35. Chapter 31: ANTIPSYCHOTIC AND MOOD-STABILISING AGENTS - p. 832 36. Chapter 32: ANTIULCER AGENTS - p. 870 37. Chapter 33: ANTIVENOMS - p. 888 38. Chapter 34: ANTIVIRAL AGENTS - p. 896 39. Chapter 35: BLADDER FUNCTION DISORDER AGENTS - p. 941 40. Chapter 36: BONE AND CALCIUM REGULATING AGENTS - p. 956 41. Chapter 37: CARDIAC GLYCOSIDES - p. 978 42. Chapter 38: CHOLINERGIC AND ANTICHOLINERGIC AGENTS - p. 980 43. Chapter 39: CORTICOSTEROIDS - p. 990 44. Chapter 40: COUGH SUPPRESSANTS AND EXPECTORANTS - p. 1018 45. Chapter 41: DERMATOLOGICAL AGENTS - p. 1023 46. Chapter 42: DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) - p. 1037 47. Chapter 43: DIURETICS - p. 1078 48. Chapter 44: DRUG DEPENDENCE - p. 1101 49. Chapter 45: ERECTILE DYSFUNCTION AGENTS - p. 1115 50. Chapter 46: EYE, EAR, NOSE AND THROAT AGENTS - p. 1127 51. Chapter 47: FIBRINOLYTIC AGENTS - p. 1150 52. Chapter 48: GASTROINTESTINAL AGENTS (MISCELLANEOUS) - p. 1155 53. Chapter 49: GENERAL ANAESTHETICS - p. 1171 54. Chapter 50: HAEMOPOIETIC AGENTS - p. 1183 55. Chapter 51: HAEMOSTATICS - p. 1193 56. Chapter 52: HYPOTHALAMIC AND PITUITARY HORMONES - p. 1215 57. Chapter 53: IMMUNOMODIFIERS - p. 1236 58. Chapter 54: LAXATIVES - p. 1284 59. Chapter 55: LIPID REGULATING AGENTS - p. 1298 60. Chapter 56: LOCAL ANAESTHETICS - p. 1320 61. Chapter 57: METABOLIC DISORDERS AGENTS - p. 1335 62. Chapter 58: MOVEMENT DISORDER AGENTS - p. 1367 63. Chapter 59: MUSCLE RELAXANTS - p. 1401 64. Chapter 60: NEUROMUSCULAR BLOCKING AGENTS - p. 1419 65. Chapter 61: OPIOID ANALGESICS - p. 1428 66. Chapter 62: PREGNANCY, CHILDBIRTH AND BREASTFEEDING - p. 1455 67. Chapter 63: PULMONARY HYPERTENSION AGENTS - p. 1489 68. Chapter 64: SEDATIVESAND HYPNOTICS - p. 1501 69. Chapter 65: SEX HORMONES - p. 1518 70. Chapter 66: STIMULANTS - p. 1550 71. Chapter 67: SYMPATHOMIMETIC AGENTS - p. 1564 72. Chapter 68: THYROID AND ANTITHYROID AGENTS - p. 1578 73. Chapter 69: VACCINES AND IMMUNOGLOBULINS - p. 1590 74. Chapter 70: VASODILATORS - p. 1631 75. Chapter 71: VITAMINS, MINERALS AND ELECTROLYTES - p. 1635 76. Chapter 72: MISCELLANEOUS AGENTS - p. 1670 77. APPENDIX 1: POISONING AND ITS TREATMENT - p. 1681 78. APPENDIX 2: POISONS INFORMATION CENTRES - p. 1686 79. APPENDIX 3: CHANGES TO DRUG NAMES - p. 1687 80. BIBLIOGRAPHY - p. 1689 81. GLOSSARY - p. 1708 82. INDEX - p. 1715 83. Inside Back Cover - p. 1715

Indice
Autores
Muestra
Ficha Técnica